Copyright
©The Author(s) 2018.
World J Gastroenterol. Sep 14, 2018; 24(34): 3898-3907
Published online Sep 14, 2018. doi: 10.3748/wjg.v24.i34.3898
Published online Sep 14, 2018. doi: 10.3748/wjg.v24.i34.3898
Table 4 Multivariate analysis of the correlation between clinicopathological parameters and survival time of patients with gastric cancer
Covariates | Coefficient | Standard error | HR | 95%CI for HR | P value |
CDK5RAP3 expression (high vs low) | -1.226 | 0.735 | 0.294 | 0.070-1.239 | 0.095 |
DDRGK1 expression (high vs. low) | -0.979 | 0.536 | 0.376 | 0.131-1.074 | 0.068 |
CDK5RAP3 and DDRGK1 expression (low/low vs. high and/or high) | 1.178 | 0.453 | 3.247 | 1.336-7.891 | 0.009 |
Depth of invasion (T3,T4 vs T1,T2) | 1.071 | 1.045 | 2.920 | 0.376-22.635 | 0.305 |
Lymph node metastasis (positive vs negative) | 1.538 | 1.020 | 1.974 | 0.631-34.367 | 0.132 |
Distant metastasis (positive vs negative) | 0.861 | 0.544 | 2.365 | 0.815-6.8631 | 0.113 |
TNM stage (stage III and IV vs I and II) | -1.630 | 0.608 | 7.195 | 0.060-0.645 | 0.007 |
- Citation: Lin JX, Xie XS, Weng XF, Zheng CH, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Li P, Huang CM. Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer. World J Gastroenterol 2018; 24(34): 3898-3907
- URL: https://www.wjgnet.com/1007-9327/full/v24/i34/3898.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i34.3898